| abstract |
A blood glucose control system and mobile medical device that provide therapy to a subject are disclosed. The disclosed systems and devices may implement one or more features that improve the user experience, such as software update technology that avoids interruption of therapy delivery, gesture-based control of therapy delivery, automatic resumption of therapy after a user-initiated pause, improved alert management , displays auto-computed dose recommendations, WAN connectivity and safety features. |